Showing results (2141-2150 of 2,454) with videos related to

Sort By:
Pageof 246
BMC Urology|March 27, 2024
Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer centerPhilipp Krausewitz, Thomas Büttner, Marthe von Danwitz, et al.
BMC Urology|March 27, 2024
Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signatureChao Tang, Yanpeng Fan, Shusheng Zhu
BMC Urology|March 27, 2024
Quantitative differentiation of non-invasive bladder urothelial carcinoma and inverted papilloma based on CT urographyPengfei Jin, Liqin Yang, Yitao Liu, et al.
BMC Urology|March 13, 2024
A contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinomaEdouard Nicaise, Adam S Feldman, Andrew Gusev, et al.
BMC Urology|January 25, 2024
Evaluating noninvasive brain stimulation to treat overactive bladder in individuals with multiple sclerosis: a randomized controlled trial protocolBetsy H Salazar, Kristopher A Hoffman, John A Lincoln, et al.
BMC Urology|January 23, 2024
Association of estimated glomerular filtration rate with prostate cancer risk in a cross-ethnic population: a Mendelian randomization studyHaojian Zhang, Tian Li, Yingjie Jia
BMC Urology|December 11, 2023
Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar ratIdris Idowu Bello, Akinyinka Omigbodun, Imran Morhason-Bello
BMC Urology|July 3, 2024
Relationship between prostate-specific antigen, alkaline phosphatase levels, and time-to-tumor shrinkage: understanding the progression of prostate cancer in a longitudinal studyMadiha Liaqat, Rehan Ahmad Khan, Florian Fischer, et al.
BMC Urology|July 12, 2024
Using fosfomycin to prevent infection following ureterorenoscopy in response to shortage of cephalosporins: a retrospective preliminary studyToshiki Etani, Chiharu Wachino, Takuya Sakata, et al.
BMC Urology|July 25, 2024
Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)Marshall Diven, Karla Ballman, Ariel Marciscano, et al.
Pageof 246